The current study did not evaluate the difference in HRQOL of other anti-diabetes medications such as sodium glucose transporter inhibiters and incretin mimetics that are usually combined with one or more of selected anti-diabetes medications. This evidence concerns the gene GCG and diabetes mellitus.